Assessing feasible business models for commercialisation of cell therapies. (2018)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Other